Skin Toxicity Due to Mercaptopurine in Maintenance Therapy Among Children With Acute Lymphoblastic Leukemia

被引:1
|
作者
Higgerson, Kayeleigh [1 ,2 ]
Flatt, Terrie [1 ]
机构
[1] Childrens Mercy Hosp, BMT, Dept Pediat Hematol Oncol, Kansas City, MO USA
[2] Childrens Mercy Hosp, 2401 Gillham Rd, Kansas City, MO 64108 USA
关键词
mercaptopurine; acute lymphoblastic leukemia; skin toxicity; allopurinol; thiopurine metabolites; 6MMPN; ALLOPURINOL; METABOLITES; 6-MERCAPTOPURINE;
D O I
10.1097/MPH.0000000000002667
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mercaptopurine is a crucial component in the treatment of acute lymphoblastic leukemia. It is associated with toxicities that can delay treatment. Mercaptopurine is metabolized into 6-thioguanine nucleotides and 6-methylomercaptopurine nucleotides (6MMPN). Accumulation of 6MMPN has previously been associated with hepatotoxicity, pancreatitis, and hypoglycemia. However, skin toxicity has rarely been reported. We report 5 cases of elevated 6MMPN levels associated with cutaneous manifestations.
引用
收藏
页码:E514 / E517
页数:4
相关论文
共 50 条
  • [31] Cryptosporidiosis in Children With Acute Lymphoblastic Leukemia on Maintenance Chemotherapy
    Domenech, Carine
    Rabodonirina, Meja
    Bleyzac, Nathalie
    Pages, Marie-Pierre
    Bertrand, Yves
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2011, 33 (07) : 570 - 572
  • [32] IS MAINTENANCE THERAPY NECESSARY FOR ACUTE LYMPHOBLASTIC-LEUKEMIA
    SESHADRI, R
    TURNER, DR
    LANCET, 1986, 2 (8504): : 452 - 453
  • [33] THE COURSE OF BIOLOGICAL PARAMETERS AND 6-MERCAPTOPURINE PHARMACOKINETICS DURING MAINTENANCE TREATMENT OF CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    HAYDER, S
    BJORK, O
    LAFOLIE, P
    ACTA PAEDIATRICA SCANDINAVICA, 1990, 79 (8-9): : 832 - 837
  • [34] Immunogenicity of Trivalent Influenza Vaccine in Children With Acute Lymphoblastic Leukemia During Maintenance Therapy
    Shahgholi, Elham
    Ehsani, Mohammad Ali
    Salamati, Payman
    Maysamie, Alipasha
    Sotoudeh, Kambiz
    Mokhtariazad, Talat
    PEDIATRIC BLOOD & CANCER, 2010, 54 (05) : 716 - 720
  • [35] Physicians compliance during maintenance therapy in children with Down syndrome and acute lymphoblastic leukemia
    C Bohnstedt
    M Levinsen
    S Rosthøj
    B Zeller
    M Taskinen
    S Hafsteinsdottir
    H Björgvinsdóttir
    M Heyman
    K Schmiegelow
    Leukemia, 2013, 27 : 866 - 870
  • [36] Physicians compliance during maintenance therapy in children with Down syndrome and acute lymphoblastic leukemia
    Bohnstedt, C.
    Levinsen, M.
    Rosthoj, S.
    Zeller, B.
    Taskinen, M.
    Hafsteinsdottir, S.
    Bjorgvinsdottir, H.
    Heyman, M.
    Schmiegelow, K.
    LEUKEMIA, 2013, 27 (04) : 866 - 870
  • [37] Socioeconomic position and maintenance therapy in children with acute lymphoblastic leukemia: A national cohort study
    Pedersen, Line Hjollund
    Ostergaard, Anna
    Bank, Victoria
    Nersting, Jacob
    Tuckuviene, Ruta
    Wehner, Peder Skov
    Albertsen, Birgitte Klug
    Degn, Matilda
    Als-Nielsen, Bodil Elise Thorhauge
    Larsen, Hanne Baekgaard
    Schmiegelow, Kjeld
    Dalton, Susanne Oksbjerg
    PEDIATRIC BLOOD & CANCER, 2022, 69 (07)
  • [38] Investigating fine motor deficits during maintenance therapy in children with acute lymphoblastic leukemia
    Hanna, Silvia
    Elshennawy, Shorouk
    El-Ayadi, Moatasem
    Abdelazeim, Faten
    PEDIATRIC BLOOD & CANCER, 2020, 67 (07)
  • [39] Methotrexate Polyglutamate Values in Children and Adolescents With Acute Lymphoblastic Leukemia During Maintenance Therapy
    Kandikonda, Pooja
    Bostrom, Bruce
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (06) : 429 - 432
  • [40] Language, 6-mercaptopurine adherence, and relapse in children with acute lymphoblastic leukemia
    Robles, Joanna
    Chen, Yanjun
    Hageman, Lindsey
    Aristizabal, Paula
    Landier, Wendy
    Bhatia, Smita
    Wadhwa, Aman
    JNCI CANCER SPECTRUM, 2024, 8 (05)